Current Edition

Mitigating Risks of Block-enrolled Ophthalmology Studies

The use of block enrolment in ophthalmology trials helps
enrolment keep up with the speed of these studies. However,
the challenges inherent in their successful execution are
numerous. Some studies complete enrolment in a single day,
while others enroll in “blocks” over consecutive days or weeks
to take advantage of this accelerated recruitment. These
aggressive timelines create risks in the logistics of successful
study completion. Simon Chandler, PhD, Senior Director of
EU Clinical and Regulatory Operations and Jocelyn Wise
Director of Monitoring at ORA, Inc., discusses effective
practices to mitigate these risks.